chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I can't lift my arm without incurring pain at the vacine site. The pain was a 10 level and now its about a 4 level.
Patient states he had a temperature of 100.1 on 5/19/2021  for most of the day.
Headache; sore throat; other vaccine same dateproduct=Influenza Vaccine, other vaccine same date vaccinedate=14Nov2022; other vaccine same dateproduct=Influenza Vaccine, other vaccine same date vaccinedate=14Nov2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 12-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Nov2022 at 11:00 as dose 3 (booster), single (Lot number: GK1647) at the age of 12 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 14Nov2022 as dose 1, single (Batch/Lot number: unknown), in left arm for immunisation. The patient had no relevant medical history. Concomitant medication(s) included: PROBIOTICS. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: FL2757, Location of injection: Arm Left), administration date: 02Aug2022, when the patient was 11-year-old, for COVID-19 immunization, reaction(s): "Inappropriate schedule of vaccine administered"; BNT162b2 (Dose Number: 1, Batch/Lot No: FL8095, Location of injection: Arm Left), administration date: 14Jan2022, when the patient was 11-year-old, for Covid-19 immunization, reaction(s): "Inappropriate schedule of vaccine administered".  The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 14Nov2022 at 11:00, outcome "unknown" and all described as "other vaccine same dateproduct=Influenza Vaccine, other vaccine same date vaccinedate=14Nov2022"; HEADACHE (non-serious) with onset 14Nov2022 at 16:00, outcome "not recovered"; OROPHARYNGEAL PAIN (non-serious) with onset 14Nov2022 at 16:00, outcome "not recovered", described as "sore throat". Therapeutic measures were taken as a result of headache, oropharyngeal pain.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201301482 same patient, different dose number and events;
pt had a flu shot 09/21/2019. Her daughter called 09/24/2019 stating that mom has been throwing up since 09/23/2019 and her temp 99.4 she thinks it is related to shot. Pt will go to urgent care
Day after had soreness fatigue, dry thort,  cramps conipation, chills, pain at injection site.  Gone within 24 hrs but returned more severe on 08/13/2021. Again lasting 24hrs. Felling better but not completely.
Urticaria on arms legs and (L) abdomen fading on Rt cheek.
Systemic: Dizziness/Lightheadedness-Medium, Systemic: Hypertension-Medium, Additional details: Patient said he felt dizzy. We checked his blood pressure 3 times. It was 162/102 each time so we called 911. He was brought to emergency room.
DVT on 25 Jan, 1st moderna on 7 Jan 2021, 2nd moderna on 8 Feb 2021, noted LE DVT, placed on anticoagulation, which continues indef due to +FVL homozygous
Cough, dyspnea, headache, nasal congestion, postnasal drip, diarrhea.
Bumps appeared on lmy ips; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 12Apr2021 at 14:30 in the left arm (at the age of 49-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included possible penicillin allergy. The patient did not receive other medication within 2 weeks of COVID-19 vaccine. The patient did not receive other vaccination within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 25Mar2021 at 13:30 (at the age of 49-years-old) in the right arm as single dose for COVID-19 immunisation. Post the vaccination, the patient was not tested for COVID-19. On 12Apr2021, the patient was not certain what caused this but she had not experienced this before. Bumps appeared on her lips. She thought it was a cold sore at first but there was no itching tingling. One that had grown in the last couple of days on the lower lip and many smaller bumps on the upper lip not responding to Abreva, which was what she would usually use on a cold sore as soon as she felt the tingling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included Abreva (MANUFACTURER UNKNOWN). The clinical outcome of the event bumps appeared on lips was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A fast heartbeat; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL1283), via an unspecified route of administration, administered in Left Arm on 06Feb2021 03:45 am as SINGLE DOSE for covid-19 immunisation. facility type vaccine: Hospital. If covid prior vaccination: No. If covid tested post vaccination: No. Known allergies: No. Medical history included 3Rd stage kidney disease. There were no concomitant medications. If other vaccine in four weeks: No. The patient experienced a fast heartbeat (non-serious) on 06Feb2021 20:45. If treatment ae: No. The patient underwent lab tests and procedures which included heart rate: fast heart beat   on 06Feb2021. The outcome of event was unknown
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and drug reactions/allergies were not reported. On an unknown date the patients were vaccinated with unspecified doses of improperly stored VARIVAX (Merck) (lot # L017144 with expiration date 13-MAY-2017, L006386 with expiration date 25-FEB-2017, K021934 with expiration date 10-NOV-2016 and lot# reported as L025205 with expiration date 07-JUL-2017; dose, dose number and route were not reported). No adverse effects were reported. This is one of several cases from the same reporter. Additional information has been requested.
Heart problems; Stomach ache after 2nd dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 06Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Heart attack" (unspecified if ongoing), notes: She has heart problems/had a heart attack 4 years ago; "Afib" (unspecified if ongoing), notes: Thought she had AFIB and occasionally it will be 150 times a minutes. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Heart problems"; ABDOMINAL PAIN UPPER (non-serious) with onset 06Feb2021, outcome "unknown", described as "Stomach ache after 2nd dose". Relevant laboratory tests and procedures are available in the appropriate section.  Additional info: Patient was advised by her doctor to get the booster dose and wanted to make sure if it was safe for her to have it. Patient stated she had a really bad stomach ache after 2nd dose, It was hours later in the evening after her second dose on 06Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up on day #2 with pale pink rash on chest. Itching. spread to L arm by afternoon. Mild Headache. several days. MD prescribed hydroxyzine/HCL. Pt took x 5 days.  MD exempted pt from MMR #2 for school.
Starting two nights after receiving the vaccine writer started to get leg cramps, and burning pain. The pain is not similar to flu-like body aches.  This continues into the next week and is traveling to abdomen.  Writer is unable to obtain medical advice on how to proceed.
RASH TO INJECTION SITE (LEFT UPPER DELTOID REGION) WHERE SHE RECEIVED FLU VACCINE
had the shot, still got shingles/suspected vaccination failure; Still got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 9-Jan-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shot and still got shingles. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
70 doses of Pfizer-BioTech Covid Vaccine for pediatric patients (orange cap) Lot FK5618 were delivered assigned a beyond use date (BUD, do not use after date) by the manufacturer due to previous storage and handling issues at another facility.  The doses were mistakenly administered to 70 patients on 11/26/21
bad cold.; stomach started hurting; sore joints in wrist up to shoulder, and ankle; arm hurt for 3 days; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 01:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had a history of allergy to penicillin, sulfamethoxazole/trimethoprim, latex and bees. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, after vaccine shot, the patient experienced arm hurt for 3 days. On the 15Mar2021, her stomach started hurting, then after from 15Mar2021 to 20Mar2021, she had sore joints in wrist up to shoulder, and ankle. Next on the 2Mar2021, the patient felt like she had a bad cold. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm hurt for 3 days, stomach started hurting and bad cold was unknown while the outcome of sore joints in wrist up to shoulder and ankle was resolved on 20Mar2021.  No follow-up attempts are needed. No further information is expected.
pt recv vax 16APR98 & evening of 26APR98 ran a low grade fever 27APR98 woke w/a red blotchy rash on face & arms;has spread over entire body;seen by MD who said it was allergic rxn to MMR vax;prescribed ATB & anti-itch med;did throat cult;
More than 35 days after the first dose without receiving the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days after the first dose without receiving the second dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days after the first dose without receiving the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 35 days after the first dose without receiving the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient had returned for receiving the second dose on 13-Aug-2021. The pharmacist reported that the expiration date on the vial was 12/31/69. No concomitant medication information was provided. No treatment medication information were provided.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated intramuscularly with the second dose of Gardasil. Subsequently, following the second vaccination, the patient experienced irregular periods. Unspecified medical attention was sought. At the time of this report, the outcome of the event was unknown. Additional information has been requested.
pt recvd vax 1MAR93 & 12APR93 lab eval revealed anti-HBs less than 6; No further details were provided;
Rash started the next day, post vax. Left thight with 2.5cm to 3cm ecchymotic center with erythematous rash extending over thigh to just above the knee. No warmth but questionable tenderness but walks on it.
Information has been received from a pharmacy student concerning a 58 year old female with drug hypersensitivity to corticotrophin who on 13-JUL-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (LOT# not reported). On an unspecified date (In July 2010), the patient experienced shingles on her lower flank. The patient had not seen her physician but called the pharmacy and had diagnosed the shingles herself. At this time of reporting, the patient was not recovered. Additional information has been requested.
Pfizer vaccine administered after being stored at regular freezer temps longer than recommended. Dose determined invalid, client contacted and recommended repeat dose.
Chills and shivering,  fever, head ache and nausea started about 12 hours after injection. Shivering went away after I put on more layers and warmed up, fever head ache and nausea lasted for about 12 hours. Symptoms were gone approximately 36 hours after injection
Bodyache, headache, vomiting x2times and fever after  J&J shot 2days ago. Denies abdominal pain, difficult breathing or chest pain.
This spontaneous report as received from a healthcare worker refers to a patient of an unknown age and gender. The patients' relevant medical history, concurrent condition and concomitant medication were not reported. 02-NOV-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # L025737 (expiry date: 28-JUL-2017) (dosage and route were not reported). Concomitant medication was not reported. No adverse effect reported. The nurse reported a temperature excursion for the GARDASIL 9. No further details provided. This is one of several reports from the same source. Additional information has been requested.
pt recvd vax;18jul94 in eve devel inc t 103 R;v;unusual high pitch cry & inconsolable >3hrs;19jul listless,v cont w/ inc t;to MD,adm to hosp;IV started too rehydrate pt;20jul blood noted in urine;dx abnl small urethra;23jul dismissed hosp;
On 10/14/1993 at 8 months of age, the infant became ill and had an elevated WBC. She developed viral infections and ear infections on a regular basis (approximately once a month), beginning at 8 months of age. The infant's language development stopped at 16 months of age, and she had recurrent tonsillitis up to the age of 2.5 years. On 8/28/1995 at the age of 2.5 years, the child had a tonsillectomy. The mother reported the child was not engaging in imaginative play at the age of two years old. The child was examined by a psychologist and was assessed for language skills. On an unknown date, she was diagnosed with autism.
First time seizure lasting 15 seconds, unusually intense menstrual cramps, new nausea 20 minutes prior to seizure, headache, 'head cold' type symptoms several days prior to seizure.
Information has been received from a registered nurse concerning a patient who "this week" was vaccinated with a second dose of Pneumovax 23 (lot # 655586/0881F).  Subsequently the patient experienced aching and headache.  Unspecified medical attention was sought.  Additional information has been requested.
chills really bad; he was shaking all over; Muscle pain across two shoulders and arms; tired; Injection site redness; injection site pain; This is a spontaneous report from a contactable consumer (patient). An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, in the left arm, on 12Oct2021 (Lot number: EW0179), at age 82 years old, as dose 3 (booster), single, for COVID-19 immunisation. Relevant medical history included diabetic, heart problems, and lymphoedema all from unknown date, not reported if ongoing or not, and flu on an unknown date. Concomitant medications included unspecified products. Historical vaccines included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) received on 21Feb2021 (lot number: EN6203), at age 81 years old, as dose 1, single; and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) received on 14Mar2021 (lot number: EN6204), at age 81 years old, as dose 2, single, for COVID-19 immunisation. The patient did not receive prior vaccinations within 4 weeks. On 12Oct2021, the patient experienced injection site pain and injection site redness. On 13Oct2021 at 08:00, the patient started to have chills really bad, he was shaking all over. On 13Oct2021, the patient experienced muscle pain across two shoulders and arms and was tired. The patient had the shot on 12Oct2021 at noon and had no problems with it from noon until this morning. This morning at about 8:00 the caller started to have chills really bad, he was shaking all over. The caller put a heating pad on this body to warm himself up. The patient's injection site had pain but not too bad, but there was pain. The patient has taken 2 Tylenols in order to ease the pain a little bit. The caller was tired and fell asleep once he put the heating pad on him and woke up about 5 minutes ago and slept for 3 hours. The patient also had muscle pain across his two shoulders and arms. The patient had injection site redness. The patient stated it was nothing is too serious except the chills and the patient has never had anything like that not even when he had the flu. The events did not result to emergency room and physician's room visits. The outcome of the event injection site redness was not resolved. The patient was recovering from the remaining events.  No follow-up attempts are needed. No further information is expected.
pt recv vax & devel sneezing & green mucous in nose;wakes up screaming has a rattly throat sound-fever 100;MD called prescribed DPH & APAP;mom became frightened-took pt to MD dx Uri/croup vax rxn;
Felt sick; High fever; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Felt sick) and PYREXIA (High fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Heart disorder and COPD.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt sick) and PYREXIA (High fever). At the time of the report, VACCINATION COMPLICATION (Felt sick) and PYREXIA (High fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. . No treatment related information has been reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Patient last name and email address updated
Given to a 13 year old.    No adverse reaction, parents present no concerns all questions answered
PRETTY SICK; BODY ACHES; LOST WEIGHT; SHOOTING PAINS; COVID ARM (FOR A WEEK); CHILLS; NAUSEA; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: immunocompromised. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced pretty sick, body aches, lost weight, shooting pains, covid arm (for a week), chills, nausea, and fever. Laboratory data (dates unspecified) included: Lost weight (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from covid arm (for a week), and the outcome of pretty sick, fever, chills, body aches, nausea, lost weight and shooting pains was not reported. This report was non-serious.
per school health aide and guardian - patient experienced a rash/hives approximately 30 after receiving vaccine. per parent/guardian - hives was noted to the trunk, face, arms and legs on 02/09/2023. Health department notified on 02/10/2023 - per client, symptoms improved.
Information has been received from a nurse concerning an actually 36 year old female patient with allergy to yeast and bee sting and no pertinent medical history who on an unknown date was vaccinated with a dose of HepB (manufacturer unknown) (Lot# and expiration not reported). There was no concomitant medication. The nurse reported that on an unspecified date the patient had a severe anaphylactic reaction when administered a dose of HepB (manufacturer unknown). The nurse also noted that the anaphylactic reaction was found to be due to the yeast in the HepB (manufacturer unknown). The nurse stated, "This occurred a while ago". No laboratories were performed. It was unknown if the patient sought medical attention. The patient recovered on an unspecified date. No further information is available.
Chronic Cluster Headache and Ischemic Colitis  Cluster headaches have been resistant to any and all medication trials/treatments including Rizitriptan and Emgality and headaches and migraines are still affecting me daily.  Ischemic colitis and diverticulitis has just now been diagnosed (April 10, 2022) as we have been investigating the sources and causes for my abdominal pain.  We attempted to treat diverticulitis with two 10-day rounds of antibiotics in March 2022 to no avail. We are now starting treatment today with Mesalamine 1.2 g tablets.
No adverse effects were noted.  Patient was given 1st dose of rotateq vaccine at age 6 months.  Rotateq is not indicated unless first dose is given prior to this.